The DOI matches its Crossref record.
Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels
Abstract
Levosimendan, a novel calcium sensitizer developed for the treatment of acute heart failure, is an inodilator that increases coronary flow. Because it was recently shown that levosimendan stimulates potassium current through K(ATP) channels in isolated rat arterial cells, our aim was to assess whether the levosimendan-induced increase in coronary flow is due to the opening of the K(ATP) channels in coronary smooth muscle. The effect of levosimendan on the diastolic coronary flow velocity (DCFV) was measured in the Langendorff perfused spontaneously beating guinea-pig heart in the absence and presence of glibenclamide. Pinacidil was used as a reference compound, and the protein kinase C inhibitor bisindolylmaleimide was used to study the dilatory effect of levosimendan when the K(ATP) channels in smooth muscle are not inhibited by PKC-dependent phosphorylation. Levosimendan (0.01-1 microM) increased DCFV concentration-dependently and was noncompetitively antagonized by 0.1 microM glibenclamide, whereas pinacidil was inhibited competitively by glibenclamide. In the presence of glibenclamide the positive inotropic and chronotropic effects of levosimendan were unaltered. The effect of bisindolylmaleimide and levosimendan on DCFV was additive. The results indicate that levosimendan induced coronary vasodilation through the opening of the K(ATP) channels. Levosimendan and pinacidil probably have different binding sites on the K(ATP) channels. The additive effect of bisindolylmaleimide and levosimendan on the increase of DCFV suggests that the latter binds to the unphosphorylated form of the channel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Levosimendan: Molecular mechanisms and clinical implications
Papp, Z., Édes, I., Fruhwald, S., De Hert, S. G., Salmenperä, M., Leppikangas, H., Mebazaa, A., Landoni, G., Grossini, E., Caimmi, P., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.07.022 · Cited by 319
Self-citationEffects of levosimendan on systemic and regional hemodynamics in septic myocardial depression
Morelli, A., De Castro, S., Teboul, J.-L., Singer, M., Rocco, M., Conti, G., De Luca, L., Di Angelantonio, E., Orecchioni, A., Pandian, N. G., et al. (2005) · Intensive Care Medicine · doi:10.1007/s00134-005-2619-z · Cited by 303
Roeleveld, P. P., & de Klerk, J. C. A. (2018) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/2150135117731725 · Cited by 51
“By stimulating potassium channels in vascular smooth muscle cells, levosimendan causes peripheral, coronary, and pulmonary vasodilatation.(70,71) Because of these effects, levosimendan could be useful in children with congenital heart disease.”
Background
Metadata
- Authors
- Kaheinen, P., Pollesello, P., Levijoki, J., & Haikala, H.
- Venue
- Journal of Cardiovascular Pharmacology
- Published
- 2001-04
- Volume
- 37
- Issue
- 4
- Pages
- 367-374
- ISSN
- 0160-2446 (ISSN-L)
- OpenAlex
- W2323986425
- Cited by
- 162
- References
- 0
- FWCI
- 1.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels. https://app.cochat.ai/papers/10.1097/00005344-200104000-00003
- The paper
- Kaheinen, P., Pollesello, P., Levijoki, J., & Haikala, H. (2001). Levosimendan Increases Diastolic Coronary Flow in Isolated Guinea-Pig Heart by Opening ATP-Sensitive Potassium Channels. Journal of Cardiovascular Pharmacology. https://doi.org/10.1097/00005344-200104000-00003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.